Research evolution of children with sporadic Burkitt' s lymphoma

( views:380, downloads:0 )
Author:
XU Hong-yan(Department of Pathology, Jiangxi Children's Hospital, Nanchang 330006, China)
Journal Title:
Journal of Leukemia & Lymphoma
Issue:
Volume 21, Issue 10, 2012
DOI:
10.3760/cma.j.issn.1009-9921.2012.10.019
Key Word:
Lymphoma;Pathological diagnosis;Immunophenotype;Molecular genetics

Abstract: Children with sporadic Burkitt's lymphoma (BL) is a highly aggressive lymphoma.It partly overlaps with diffuse large B cell lymphoma (DLBCL) and unclassified B cell lymphoma (DLBCL/BL) which is between DLBCL and BL in the morphological,immunophenotypic and molecular genetic aspects,but it has its unique.characterization. Enhancing awareness of the disease based on the BL pathology, pathogenesis and prognosis of understanding,at the time of diagnosis and identificate with DLBCL and DLBCL/BL at the tine of diagnosis will be beneficial to clinical correct treatment and prognosis.

  • [1]Swerdlow SH,Campo E,Harris NL,et al.World Health Orgnization classification of tumours of haematopoietic and lymphoid tissues.Lyon:IARC Press,2008:262-266.
  • [2]王学文,翟勇平,冒晓蓓.伯基特淋巴瘤的临床病理学特征和鉴别诊断.临床肿瘤学杂志,2007,12:968-877.
  • [3]Gualco G,Queiroga EM,Weiss LM,et al. Frequent expression of multiple myeloma 1/interferon regulatory factor 4 in Burkitt lymphoma.Hum Pathol,2009,40:565-571.
  • [4]杨文萍,黄慧,宫丽平,等.儿童散发性伯基特淋巴瘤的分子遗传学特征分析.中华病理学杂志,2010,39:819-824.
  • [5]吕蓓蓓,周春菊,杨文萍,等.儿童侵袭性成熟B细胞淋巴瘤的临床病理学及分子遗传学特点.白血病·淋巴瘤,2011,20:154-158.
  • [6]Chuang SS, Ye H, Du MQ, et al. Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH.Am J Clin Pathol,2007,128:558-564.
  • [7]Dave SS,Fu K,Wright GW,et al.Molecular diagnosis of Burkitt's lymphoma.N Engl J Med,2006,354:2431-2442.
  • [8]Rodig SJ,Vergilio JA,Shahsafaei A,et al.Characteristic Expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a myc translocation.Am J Surg Pathol,2008,32:113-122.
  • [9]水若鸿,陆洪芬,朱雄增.T细胞淋巴瘤1和CD44蛋白在Burkitt 淋巴瘤中的表达及其诊断价值.中华病理学杂志,2009,38:745-748.
  • [10]Herling M,Patel KA,His ED,et al.TCL1 in B-cell tumors retains its normal B-cell pattern of regulation and is a marker of dlfferentiation stage.Am J Surg Pathol,2007,31:1123-1129.
  • [11]Teitell MA, Lones MA,Perkins SL, et al. TCL1 Expression and Epstein-Barr Virus Status in Pediatric Burkitt Lymphoma.Am J Clin Pathol,2005,124:569-575.
  • [12]Devergne O,Hummel M,Koeppen H,et al.A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphoeytes.J Virel,1996,70:1143-1153.
  • [13]Gonin J,Larousserie F,Bastard C,et al.Epstein-Barr virus-induced gene 3 (EBI3):a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma.PLoS One,2011,6:e24617.
  • [14]Privado IM, Mart í nez MR,Rebollo P,et al. E2F1 expression is deregulated and plays an oncogenic role in sporadic Burkitt's lymphoma.Cancer Res,2009,69:4052-4058.
  • [15]Onnis A, Falco GD, Antonicelli G, et al. Alteration of microroRNAs regulated by c-myc in Burkitt's lymphoma. PLoS One, 2010, 5:e12960.
  • [16]Salaverria I,Zettl A,Bea S,et al.Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expressiondefined Burkitt's lymphoma.Haematologica,2008,93:1327-1334.
  • [17]Garcia JL,Hemandez JM,Gutierrzz NC,et al.Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt' lymphoma. A cytogenetic and comparative genomic hybridization study.Leukemia,2003,17:2016-2024.
  • [18]Hecbt J, Aster J. Molecular biology of Burkitt's lymphoma.J Clin Oncol,2000,18:3703-3721.
  • [19]Miles RR,Raphael M,McCarthy K,et al.Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype:report of the French-American-British (FAB) international study group.Pediatr Blood Cancer,2008,51:369-374.
  • [20]Gualco G,Weiss LM,Harrington W J,et al.Nodal diffuse large B-cell lymphomas in children and adolescents:immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome.Am J Surg Pathol,2009,33:1815-1822.
  • [21]Robertus JL,Kluiver J,Weggemans C,et al.MiRNA pro?ling in B non-Hodgkin lymphoma:a MYC-related miRNA profile characterizes Burkitt lymphoma.Br J Haematol,2010,149:896-899.
  • [22]O'Donnell KA, Wentzel EA, Zeller KI, et al. c-Myc-regulated microRNAs modulate E2F1 expression.Nature,2005,435:839-843.
  • [23]Leueci E, Cocco M, Onnis A, et al. MYC translocation-negative classical Burkitt lymphoma cases: an alteruative pathogenetic mechanism involving miRNA deregulation.J Pathol,2008,216:440-450.
  • [24]Lones MA,Sanger WG,LeBeau MM,et al.Chromosome abnormalities may correlate with prognosis in Burkitt/Burkitt-like lymphomas of children and adolescents:a report from Children's Cancer Group Study CCG-E08.J Pediatr Hematol,2004,26:169-178.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn